Many were waiting for China’s PMI Index to reveal economic slowing, and it did dropping to 47 from 47.3. The decline looks modestly weak even if you accept their calculations to be fairly done, but the real news is this
September 23, 2015
Heron Therapeutics, Inc. (HRTX – Snapshot Report) announced positive, top-line data from a phase II study on HTX-011 for the management of post-operative pain in patients undergoing bunionectomy. The candidate is developed using Heron’s proprietary Biochronomer drug delivery technology. We expect investors to